Trial Profile
Efficacy of dose escalation in Chinese patients with advanced GIST after 400mg imatinib resistance: a prospective study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Apr 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- Sponsors Novartis
- 21 Nov 2009 New trial record